Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Scalp block with or without magnesium adjunct for chronic subdural hematoma evacuation
PACTR202311549336413Phase 3Completed
- Sponsor
- Kasr Al Ainy Hospital
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of magnesium sulfate, bupivacaine and lidocaine in Chronic subdural haematoma (CSDH) (2 arms), sponsored by Kasr Al Ainy Hospital. Primary endpoint: Time to first dose of postoperative analgesia. Started Nov 2022; status: completed.
02
Drugs
magnesium sulfatebupivacainelidocaine
03
Conditions
Chronic subdural haematoma (CSDH)
Beyond the preview
Go deeper on PACTR202311549336413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202311549336413.